Sewoon Medical Co., Ltd (KOSDAQ: 100700)
South Korea
· Delayed Price · Currency is KRW
2,805.00
+5.00 (0.18%)
Oct 8, 2024, 9:00 AM KST
Sewoon Medical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 14,145 | 14,957 | 10,406 | 12,282 | 10,496 | 9,476 | Upgrade
|
Depreciation & Amortization | 3,540 | 3,648 | 3,888 | 3,836 | 3,684 | 3,497 | Upgrade
|
Loss (Gain) From Sale of Assets | -16.99 | -17.79 | -2.2 | 0.67 | 8.81 | 334.47 | Upgrade
|
Asset Writedown & Restructuring Costs | -2.5 | -1.22 | 2 | -7.63 | 226.83 | 512.38 | Upgrade
|
Provision & Write-off of Bad Debts | 5.36 | -1.25 | -15.31 | -22.77 | -44.31 | 32.76 | Upgrade
|
Other Operating Activities | -210.35 | 2,807 | -1,861 | 2,413 | 2,179 | 1,496 | Upgrade
|
Change in Accounts Receivable | 110.58 | 372.12 | -1,150 | 1,672 | 2,236 | -1,759 | Upgrade
|
Change in Inventory | -1,558 | 203.91 | -1,177 | 2,077 | -508.68 | -1,198 | Upgrade
|
Change in Accounts Payable | 87.43 | -92.73 | -418.94 | -271.82 | 492.94 | 536.13 | Upgrade
|
Change in Other Net Operating Assets | 756.73 | 1,201 | -393.25 | -508.66 | 481.34 | 552.85 | Upgrade
|
Operating Cash Flow | 16,857 | 23,076 | 9,279 | 21,469 | 19,252 | 13,481 | Upgrade
|
Operating Cash Flow Growth | -14.51% | 148.71% | -56.78% | 11.52% | 42.81% | 10.55% | Upgrade
|
Capital Expenditures | -1,712 | -1,949 | -2,151 | -2,224 | -2,274 | -5,934 | Upgrade
|
Sale of Property, Plant & Equipment | 429.6 | 609.45 | 369.82 | 296.88 | 331.32 | 728.57 | Upgrade
|
Cash Acquisitions | - | - | - | - | - | -492.15 | Upgrade
|
Divestitures | - | - | - | - | 776.67 | - | Upgrade
|
Sale (Purchase) of Intangibles | -3.41 | -6.59 | -17.12 | -265.02 | -1,214 | -25.73 | Upgrade
|
Investment in Securities | 25,082 | 24,989 | -18,010 | -6,986 | 45.37 | -15.69 | Upgrade
|
Other Investing Activities | 34.3 | 0.27 | -12.84 | 2 | -195.55 | 17.96 | Upgrade
|
Investing Cash Flow | 23,830 | 23,642 | -19,821 | -9,177 | -2,530 | -5,608 | Upgrade
|
Short-Term Debt Repaid | - | - | - | - | - | -2,340 | Upgrade
|
Long-Term Debt Repaid | - | -295.87 | -297.92 | -275.49 | -151.81 | -266.32 | Upgrade
|
Total Debt Repaid | -277.14 | -295.87 | -297.92 | -275.49 | -151.81 | -2,606 | Upgrade
|
Net Debt Issued (Repaid) | -277.14 | -295.87 | -297.92 | -275.49 | -151.81 | -2,606 | Upgrade
|
Dividends Paid | -3,030 | -2,597 | -2,165 | -2,165 | -2,165 | -2,165 | Upgrade
|
Financing Cash Flow | -3,308 | -2,893 | -2,462 | -2,440 | -2,316 | -4,771 | Upgrade
|
Foreign Exchange Rate Adjustments | 349.25 | -118.43 | 156.3 | 361.33 | -112.19 | -16.65 | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | - | - | - | - | -371.41 | Upgrade
|
Net Cash Flow | 37,729 | 43,707 | -12,849 | 10,213 | 14,293 | 2,715 | Upgrade
|
Free Cash Flow | 15,145 | 21,127 | 7,128 | 19,244 | 16,978 | 7,547 | Upgrade
|
Free Cash Flow Growth | -15.13% | 196.41% | -62.96% | 13.35% | 124.98% | 11.30% | Upgrade
|
Free Cash Flow Margin | 23.35% | 30.96% | 11.86% | 30.75% | 26.64% | 11.29% | Upgrade
|
Free Cash Flow Per Share | 349.41 | 488.02 | 164.65 | 444.53 | 392.19 | 174.32 | Upgrade
|
Cash Interest Paid | 15.32 | - | - | - | 31.63 | 34.64 | Upgrade
|
Cash Income Tax Paid | 4,548 | 2,360 | 4,920 | 1,410 | 3,709 | 3,494 | Upgrade
|
Levered Free Cash Flow | 10,164 | 16,336 | 4,115 | 16,161 | 13,411 | 8,195 | Upgrade
|
Unlevered Free Cash Flow | 10,184 | 16,358 | 4,137 | 16,180 | 13,431 | 8,232 | Upgrade
|
Change in Net Working Capital | 1,078 | -4,091 | 5,200 | -5,217 | -4,548 | -127.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.